缺血性卒中血栓通透性与可区分的蛋白质组学特征及对ADAMTS13增强溶栓的易感性相关
研究对59例取出的血栓行定量质谱分析,比较高通透性(≥11 HU)与低通透性(<11 HU)血栓的蛋白质组差异,并行体外溶栓实验;结果高通透性血栓蛋白质组特征不同,且对ADAMTS13增强的tPA溶栓更敏感。
要点
- CT血栓通透性≥11 HU与<11 HU的血栓蛋白质组特征不同。
- 高通透性血栓中巨噬细胞标志物CD14及单核/巨噬细胞相关蛋白丰度降低。
- 体外实验中高通透性血栓对ADAMTS13增强的tPA溶栓更敏感。
核心结论
- 血栓通透性与复杂蛋白质组特征相关,高通透性血栓中血小板相关蛋白丰度不同且单核/巨噬细胞蛋白耗竭,这可能解释高通透性血栓对ADAMTS13增强溶栓更敏感。
研究设计与样本
- 对59例患者取出的血栓行定量质谱分析,比较高通透性(≥11 HU)与低通透性(<11 HU)血栓的蛋白质组差异,并将通透性作为连续变量与蛋白丰度相关分析,最后行体外溶栓实验检测对tPA、脱氧核糖核酸酶和ADAMTS13溶栓的敏感性差异。
诊断标准与关键数值
- 血栓通透性以CT增强前后颅内动脉闭塞血栓的衰减差值定义,高通透性为≥11 HU,低通透性为<11 HU。
- 共鉴定2790种不同蛋白质。
- 高通透性血栓中巨噬细胞标志物CD14耗竭(P=0.039,z=1.176),血红蛋白亚基ζ耗竭(P=0.046,z=1.68)。
- 血小板细胞骨架重塑相关蛋白(原肌球蛋白α-3链)及颗粒分泌/聚集相关蛋白(突触结合蛋白样蛋白4/Fc区受体II-a)与通透性增加相关(P<0.006)。
- 单核/巨噬细胞相关蛋白(含CARD的凋亡相关斑点样蛋白/SAMHD1)在高通透性栓子中耗竭(P<0.002)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Perviousness is the differential attenuation on CT of an intracranial arterial occlusive thrombus before and after IV contrast administration. While perviousness/permeability has been shown to be related to various clinical outcomes and reflects histopathologic composition, it remains unclear whether perviousness is also associated with differences in proteomic composition.
MATERIALS AND METHODS: Retrieved clots from 59 patients were evaluated with quantitative mass spectrometry. Proteomic differences between high-perviousness (≥11 HU) and low-perviousness (<11 HU) clots were investigated. Perviousness as a continuous variable was also correlated with protein abundance. Last, an ex vivo lysis assay was performed to investigate the differential susceptibility to tPA, deoxyribonuclease, and ADAMTS13 thrombolysis as a function of perviousness.
RESULTS: In total, 2790 distinct proteins were identified. Thrombus perviousness was associated with distinct proteomic features, including depletion of the macrophage marker CD14 (P = .039, z = 1.176) and hemoglobin subunit ζ (P = .046, z = 1.68) in pervious clots. Additionally, proteins involved in platelet cytoskeleton remodeling (tropomyosin α-3-chain) and granule secretion/aggregation (synaptotagmin-like protein 4/FC region receptor II-a) were associated with increasing perviousness (P < .006), among numerous other proteins. Monocyte/macrophage-associated proteins (apoptosis-associated specklike protein containing a CARD/SAMHD1) were also depleted in pervious emboli (P < .002). Ex vivo lysis indicated that pervious clots were more susceptible to ADAMTS13-augmented tPA thrombolysis compared with impervious clots (P < .05), though without differences in deoxyribonuclease digestion.
CONCLUSIONS: Thrombus perviousness is associated with complex proteomic features, including differential abundance of platelet-related proteins in highly permeable clots with monocyte/macrophage depletion. This association may help to explain why highly pervious thrombi were also found more susceptible to ADAMTS13-augmented thrombolysis.
引用
- Schartz D, Akkipeddi SMK, Rahmani R, et al. Ischemic Stroke Thrombus Perviousness Is Associated with Distinguishable Proteomic Features and Susceptibility to ADAMTS13-Augmented Thrombolysis. AJNR Am J Neuroradiol. 2023. PMID: 38123915. doi:10.3174/ajnr.A8069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。